| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.sandu.in | |
| Financial Indicators | ||
|---|---|---|
| Market Cap | 39.09 Cr. | |
| Earnings per share (EPS) | 1.54 | Trailing Twelve Months Ending 2021-03 |
| Price-Earning Ratio (PE) | 35.76 | Trailing Twelve Months Ending 2021-03 |
| Industry PE | 34.39 | Trailing Twelve Months Ending 2021-03 |
| Book Value / Share | 33.04 | Trailing Twelve Months Ending 2021-03 |
| Price to Book Value | 1.67 | Calculated using Price: 55.20 |
| Dividend Yield | 0.00 | Period Ending 2020-03 |
| No. of Shares Subscribed | 0.71 Cr. | 7,081,000 Shares |
| FaceValue | 10 | |
| Company Profile | ||
|
Sandu Pharmaceuticals incorporated in 1985, is engaged in manufacturing of ayurvedic medicines. The company operates a distribution network in India as well as in the overseas markets. The company is part of Sandu Group of Companies, which was established in the year in 1899. It is also developing bio-technology and has got encouraging results for the residual, waste products generated after extraction of green herbs, roots, etc. The company’s state-of-the-art manufacturing unit is located at Plot No. 25, 26, 29 and 30, Pilerne Industrial Estate, Marra, Bardez, Goa 403511. Sandu Pharmaceuticals has received ISO 9001-2000 certification for its quality management. It has also commenced operations of its ‘Sandu Ayurvedic Therapy Centre’, which its plans to establish centres across India via franchisee business model. |
||
Company Profile
Sandu Pharmaceuticals incorporated in 1985, is engaged in manufacturing of ayurvedic medicines. The company operates a distribution network in India as well as in the overseas markets.
The company is part of Sandu Group of Companies, which was established in the year in 1899. It is also developing bio-technology and has got encouraging results for the residual, waste products generated after extraction of green herbs, roots, etc.
The company’s state-of-the-art manufacturing unit is located at Plot No. 25, 26, 29 and 30, Pilerne Industrial Estate, Marra, Bardez, Goa 403511.
Sandu Pharmaceuticals has received ISO 9001-2000 certification for its quality management.
It has also commenced operations of its ‘Sandu Ayurvedic Therapy Centre’, which its plans to establish centres across India via franchisee business model.
| 1 Day |
|
+0.54% |
| 1 Week |
|
-1.86% |
| 1 Month |
|
+0.27% |
| 3 Month |
|
+19.23% |
| 6 Month |
|
+71.30% |
| 1 Year |
|
+200.0% |
| 2 Year |
|
+317.29% |
| 5 Year |
|
+68.18% |
| 9 years | 2012-03 | 2013-03 | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | |
| Return on Equity (%) | 2.90 | 4.50 | 2.76 | 2.28 | 2.92 | -2.44 | 3.09 | 3.53 | 3.66 | |
| Return on Capital Employed (%) | 8.23 | 7.66 | 6.93 | 6.80 | 7.65 | 5.30 | 7.06 | 7.58 | 5.79 | |
| Return on Assets (%) | 2.03 | 2.65 | 1.41 | 1.06 | 1.30 | -1.01 | 1.23 | 1.52 | 1.69 |
| Particulars | 9 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Shh. Funds | 17 | 18 | 18 | 18 | 19 | 27 | 28 | 29 | 29 | |
| Non Curr. Liab. | 1 | 2 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | |
| Curr. Liab. | 7 | 14 | 16 | 21 | 21 | 18 | 15 | 14 | 11 | |
| Minority Int. | ||||||||||
| Equity & Liab. | 26 | 33 | 37 | 42 | 41 | 46 | 45 | 44 | 41 | |
| Non Curr. Assets | 7 | 9 | 10 | 9 | 9 | 18 | 24 | 24 | 19 | |
| Curr. Assets | 18 | 24 | 27 | 32 | 33 | 28 | 21 | 20 | 22 | |
| Misc. Exp. not W/O | ||||||||||
| Total Assets | 26 | 33 | 37 | 42 | 41 | 46 | 45 | 44 | 41 |
| Particulars | 9 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Net Sales | 31 | 30 | 36 | 40 | 41 | 43 | 49 | 49 | 48 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |
| Total Income | 31 | 31 | 36 | 40 | 41 | 43 | 49 | 50 | 49 | |
| Total Expenditure | -29 | -28 | -34 | -37 | -38 | -41 | -47 | -47 | -47 | |
| PBIDT | 2 | 2 | 2 | 3 | 3 | 2 | 3 | 3 | 2 | |
| Interest | -1 | -1 | -1 | -1 | -2 | -1 | -1 | -1 | 0 | |
| Depreciation | 0 | 0 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
| Taxation | -1 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | |
| Exceptional Items | 0 | |||||||||
| PAT | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 |
| Particulars | 9 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 5 | -1 | 5 | -1 | 5 | 1 | 4 | 6 | |
| Cash Fr. Inv. | -1 | -2 | -1 | 0 | 0 | -1 | -1 | 0 | 0 | |
| Cash Fr. Finan. | 0 | 0 | 0 | -2 | -2 | -2 | -2 | -4 | -5 | |
| Net Change | 0 | 3 | -2 | 3 | -3 | 2 | -1 | -1 | 1 | |
| Cash & Cash Eqvt | 1 | 3 | 1 | 4 | 1 | 3 | 1 | 1 | 2 |
|
Thu, 22 Jul 2021
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements )Regulation 2015 for Stop Transfer.-SHILA DILIPKUMAR GOLECHHA |
|
Wed, 21 Jul 2021
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements )Regulation 2015 for Stop Transfer of Mr Anil Shah |
|
Mon, 19 Jul 2021
Shareholding for the Period Ended June 30 2021 Sandu Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here |
| Thu, 29 Jul 2021 |
Strongly Outperforming Benchmark Index
|
Strongly Outperforming Sectoral Index
|
Close Within 2 Year High Zone
|
Close Within 5 Year High Zone
|
Both SRS And ARS Above Zero
|
Equities
M.F.
Sectors